China Hydroxycarbamide Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Hydroxycarbamide Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Hydroxycarbamide Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Hydroxycarbamide Overall Market Size
2.1 China Hydroxycarbamide Market Size: 2021 VS 2027
2.2 China Hydroxycarbamide Revenue, Prospects & Forecasts: 2016-2027
2.3 China Hydroxycarbamide Sales: 2016-2027
3 Company Landscape
3.1 Top Hydroxycarbamide Players in China Market
3.2 Top China Hydroxycarbamide Companies Ranked by Revenue
3.3 China Hydroxycarbamide Revenue by Companies
3.4 China Hydroxycarbamide Sales by Companies
3.5 China Hydroxycarbamide Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hydroxycarbamide Companies in China Market, by Revenue in 2020
3.7 Manufacturers Hydroxycarbamide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hydroxycarbamide Players in China Market
3.8.1 List of Tier 1 Hydroxycarbamide Companies in China
3.8.2 List of Tier 2 and Tier 3 Hydroxycarbamide Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Hydroxycarbamide Market Size Markets, 2021 & 2027
4.1.2 Capsule
4.1.3 Tablet
4.2 By Type - China Hydroxycarbamide Revenue & Forecasts
4.2.1 By Type - China Hydroxycarbamide Revenue, 2016-2021
4.2.2 By Type - China Hydroxycarbamide Revenue, 2022-2027
4.2.3 By Type - China Hydroxycarbamide Revenue Market Share, 2016-2027
4.3 By Type - China Hydroxycarbamide Sales & Forecasts
4.3.1 By Type - China Hydroxycarbamide Sales, 2016-2021
4.3.2 By Type - China Hydroxycarbamide Sales, 2022-2027
4.3.3 By Type - China Hydroxycarbamide Sales Market Share, 2016-2027
4.4 By Type - China Hydroxycarbamide Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Hydroxycarbamide Market Size, 2021 & 2027
5.1.2 Sickle Cell Disease
5.1.3 Cancer
5.1.4 Others
5.2 By Application - China Hydroxycarbamide Revenue & Forecasts
5.2.1 By Application - China Hydroxycarbamide Revenue, 2016-2021
5.2.2 By Application - China Hydroxycarbamide Revenue, 2022-2027
5.2.3 By Application - China Hydroxycarbamide Revenue Market Share, 2016-2027
5.3 By Application - China Hydroxycarbamide Sales & Forecasts
5.3.1 By Application - China Hydroxycarbamide Sales, 2016-2021
5.3.2 By Application - China Hydroxycarbamide Sales, 2022-2027
5.3.3 By Application - China Hydroxycarbamide Sales Market Share, 2016-2027
5.4 By Application - China Hydroxycarbamide Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Overview
6.1.3 Bristol Myers Squibb Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.1.4 Bristol Myers Squibb Hydroxycarbamide Product Description
6.1.5 Bristol Myers Squibb Recent Developments
6.2 Taj Pharma
6.2.1 Taj Pharma Corporation Information
6.2.2 Taj Pharma Overview
6.2.3 Taj Pharma Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.2.4 Taj Pharma Hydroxycarbamide Product Description
6.2.5 Taj Pharma Recent Developments
6.3 Beijing Jialin Pharma
6.3.1 Beijing Jialin Pharma Corporation Information
6.3.2 Beijing Jialin Pharma Overview
6.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.3.4 Beijing Jialin Pharma Hydroxycarbamide Product Description
6.3.5 Beijing Jialin Pharma Recent Developments
6.4 Qilu Pharmaceutical
6.4.1 Qilu Pharmaceutical Corporation Information
6.4.2 Qilu Pharmaceutical Overview
6.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.4.4 Qilu Pharmaceutical Hydroxycarbamide Product Description
6.4.5 Qilu Pharmaceutical Recent Developments
6.5 Teva Pharma
6.5.1 Teva Pharma Corporation Information
6.5.2 Teva Pharma Overview
6.5.3 Teva Pharma Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.5.4 Teva Pharma Hydroxycarbamide Product Description
6.5.5 Teva Pharma Recent Developments
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Overview
6.6.3 Cipla Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.6.4 Cipla Hydroxycarbamide Product Description
6.6.5 Cipla Recent Developments
6.7 Zydus Cadila
6.7.1 Zydus Cadila Corporation Information
6.7.2 Zydus Cadila Overview
6.7.3 Zydus Cadila Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.7.4 Zydus Cadila Hydroxycarbamide Product Description
6.7.5 Zydus Cadila Recent Developments
6.8 United Biotech
6.8.1 United Biotech Corporation Information
6.8.2 United Biotech Overview
6.8.3 United Biotech Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.8.4 United Biotech Hydroxycarbamide Product Description
6.8.5 United Biotech Recent Developments
6.9 Par Pharma
6.9.1 Par Pharma Corporation Information
6.9.2 Par Pharma Overview
6.9.3 Par Pharma Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.9.4 Par Pharma Hydroxycarbamide Product Description
6.9.5 Par Pharma Recent Developments
6.10 Khandelwal Laboratories
6.10.1 Khandelwal Laboratories Corporation Information
6.10.2 Khandelwal Laboratories Overview
6.10.3 Khandelwal Laboratories Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.10.4 Khandelwal Laboratories Hydroxycarbamide Product Description
6.10.5 Khandelwal Laboratories Recent Developments
6.11 Alkem (Cytomed)
6.11.1 Alkem (Cytomed) Corporation Information
6.11.2 Alkem (Cytomed) Overview
6.11.3 Alkem (Cytomed) Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.11.4 Alkem (Cytomed) Hydroxycarbamide Product Description
6.11.5 Alkem (Cytomed) Recent Developments
6.12 Samarth Pharma
6.12.1 Samarth Pharma Corporation Information
6.12.2 Samarth Pharma Overview
6.12.3 Samarth Pharma Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.12.4 Samarth Pharma Hydroxycarbamide Product Description
6.12.5 Samarth Pharma Recent Developments
6.13 VHB Life Sciences
6.13.1 VHB Life Sciences Corporation Information
6.13.2 VHB Life Sciences Overview
6.13.3 VHB Life Sciences Hydroxycarbamide Sales and Revenue in China Market (2016-2021)
6.13.4 VHB Life Sciences Hydroxycarbamide Product Description
6.13.5 VHB Life Sciences Recent Developments
7 China Hydroxycarbamide Production Capacity, Analysis
7.1 China Hydroxycarbamide Production Capacity, 2016-2027
7.2 Hydroxycarbamide Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Hydroxycarbamide Supply Chain Analysis
9.1 Hydroxycarbamide Industry Value Chain
9.2 Hydroxycarbamide Upstream Market
9.3 Hydroxycarbamide Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Hydroxycarbamide Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Hydroxycarbamide in China Market
Table 2. Top Hydroxycarbamide Players in China Market, Ranking by Revenue (2019)
Table 3. China Hydroxycarbamide Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Hydroxycarbamide Revenue Share by Companies, 2016-2021
Table 5. China Hydroxycarbamide Sales by Companies, (M Units), 2016-2021
Table 6. China Hydroxycarbamide Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hydroxycarbamide Price (2016-2021) & (USD/K Unit)
Table 8. Manufacturers Hydroxycarbamide Product Type
Table 9. List of Tier 1 Hydroxycarbamide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Hydroxycarbamide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Capsule
Table 12. Major Manufacturers of Tablet
Table 13. By Type - China Hydroxycarbamide Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Hydroxycarbamide Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Hydroxycarbamide Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Hydroxycarbamide Sales (M Units), 2016-2021
Table 17. By Type - China Hydroxycarbamide Sales (M Units), 2022-2027
Table 18. By Application - China Hydroxycarbamide Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Hydroxycarbamide Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Hydroxycarbamide Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Hydroxycarbamide Sales (M Units), 2016-2021
Table 22. By Application - China Hydroxycarbamide Sales (M Units), 2022-2027
Table 23. Bristol Myers Squibb Corporation Information
Table 24. Bristol Myers Squibb Description and Major Businesses
Table 25. Bristol Myers Squibb Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 26. Bristol Myers Squibb Hydroxycarbamide Product
Table 27. Bristol Myers Squibb Recent Developments
Table 28. Taj Pharma Corporation Information
Table 29. Taj Pharma Description and Major Businesses
Table 30. Taj Pharma Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 31. Taj Pharma Hydroxycarbamide Product
Table 32. Taj Pharma Recent Developments
Table 33. Beijing Jialin Pharma Corporation Information
Table 34. Beijing Jialin Pharma Description and Major Businesses
Table 35. Beijing Jialin Pharma Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 36. Beijing Jialin Pharma Hydroxycarbamide Product
Table 37. Beijing Jialin Pharma Recent Developments
Table 38. Qilu Pharmaceutical Corporation Information
Table 39. Qilu Pharmaceutical Description and Major Businesses
Table 40. Qilu Pharmaceutical Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 41. Qilu Pharmaceutical Hydroxycarbamide Product
Table 42. Qilu Pharmaceutical Recent Developments
Table 43. Teva Pharma Corporation Information
Table 44. Teva Pharma Description and Major Businesses
Table 45. Teva Pharma Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 46. Teva Pharma Hydroxycarbamide Product
Table 47. Teva Pharma Recent Developments
Table 48. Cipla Corporation Information
Table 49. Cipla Description and Major Businesses
Table 50. Cipla Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 51. Cipla Hydroxycarbamide Product
Table 52. Cipla Recent Developments
Table 53. Zydus Cadila Corporation Information
Table 54. Zydus Cadila Description and Major Businesses
Table 55. Zydus Cadila Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 56. Zydus Cadila Hydroxycarbamide Product
Table 57. Zydus Cadila Recent Developments
Table 58. United Biotech Corporation Information
Table 59. United Biotech Description and Major Businesses
Table 60. United Biotech Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 61. United Biotech Hydroxycarbamide Product
Table 62. United Biotech Recent Developments
Table 63. Par Pharma Corporation Information
Table 64. Par Pharma Description and Major Businesses
Table 65. Par Pharma Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 66. Par Pharma Hydroxycarbamide Product
Table 67. Par Pharma Recent Developments
Table 68. Khandelwal Laboratories Corporation Information
Table 69. Khandelwal Laboratories Description and Major Businesses
Table 70. Khandelwal Laboratories Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 71. Khandelwal Laboratories Hydroxycarbamide Product
Table 72. Khandelwal Laboratories Recent Developments
Table 73. Alkem (Cytomed) Corporation Information
Table 74. Alkem (Cytomed) Description and Major Businesses
Table 75. Alkem (Cytomed) Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 76. Alkem (Cytomed) Hydroxycarbamide Product
Table 77. Alkem (Cytomed) Recent Developments
Table 78. Samarth Pharma Corporation Information
Table 79. Samarth Pharma Description and Major Businesses
Table 80. Samarth Pharma Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 81. Samarth Pharma Hydroxycarbamide Product
Table 82. Samarth Pharma Recent Developments
Table 83. VHB Life Sciences Corporation Information
Table 84. VHB Life Sciences Description and Major Businesses
Table 85. VHB Life Sciences Hydroxycarbamide Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Unit) (2016-2021)
Table 86. VHB Life Sciences Hydroxycarbamide Product
Table 87. VHB Life Sciences Recent Developments
Table 88. Hydroxycarbamide Production Capacity (M Units) of Key Manufacturers in China Market, 2019-2021 (M Units)
Table 89. China Hydroxycarbamide Capacity Market Share of Key Manufacturers, 2019-2021
Table 90. Hydroxycarbamide Market Opportunities & Trends in China Market
Table 91. Hydroxycarbamide Market Drivers in China Market
Table 92. Hydroxycarbamide Market Restraints in China Market
Table 93. Hydroxycarbamide Raw Materials
Table 94. Hydroxycarbamide Raw Materials Suppliers in China Market
Table 95. Typical Hydroxycarbamide Downstream
Table 96. Hydroxycarbamide Downstream Clients in China Market
Table 97. Hydroxycarbamide Distributors and Sales Agents in China Market
List of FiguresFigure 1. Hydroxycarbamide Product Picture
Figure 2. Hydroxycarbamide Segment by Type
Figure 3. Hydroxycarbamide Segment by Application
Figure 4. China Hydroxycarbamide Market Overview: 2020
Figure 5. China Hydroxycarbamide Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Hydroxycarbamide Revenue, 2016-2027 (US$, Mn)
Figure 7. Hydroxycarbamide Sales in China Market: 2016-2027 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Hydroxycarbamide Revenue in 2020
Figure 9. Capsule Product Picture
Figure 10. Tablet Product Picture
Figure 11. By Type - China Hydroxycarbamide Sales Market Share, 2016-2027
Figure 12. By Type - China Hydroxycarbamide Revenue Market Share, 2016-2027
Figure 13. By Type - China Hydroxycarbamide Price (USD/K Unit), 2016-2027
Figure 14. Sickle Cell Disease
Figure 15. Cancer
Figure 16. Others
Figure 17. By Application - China Hydroxycarbamide Sales Market Share, 2016-2027
Figure 18. By Application - China Hydroxycarbamide Revenue Market Share, 2016-2027
Figure 19. By Application - China Hydroxycarbamide Price (USD/K Unit), 2016-2027
Figure 20. Bristol Myers Squibb Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Taj Pharma Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Beijing Jialin Pharma Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Qilu Pharmaceutical Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Teva Pharma Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Cipla Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Zydus Cadila Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United Biotech Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Par Pharma Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Khandelwal Laboratories Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Alkem (Cytomed) Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Samarth Pharma Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. VHB Life Sciences Hydroxycarbamide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. China Hydroxycarbamide Production Capacity (M Units), 2016-2027
Figure 34. Hydroxycarbamide Industry Value Chain
Figure 35. Marketing Channels